These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 39251365)

  • 1. Risk of neuropsychiatric adverse events associated with montelukast use in children and adolescents: a population-based case-crossover study.
    Kim JW; Kim M; Seo MS; Shin JY
    BMJ Paediatr Open; 2024 Sep; 8(1):. PubMed ID: 39251365
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analysis of Neuropsychiatric Diagnoses After Montelukast Initiation.
    Paljarvi T; Forton J; Luciano S; Herttua K; Fazel S
    JAMA Netw Open; 2022 May; 5(5):e2213643. PubMed ID: 35608857
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of a prior authorization policy for montelukast on clinical outcomes for asthma and allergic rhinitis among children and adolescents in a state Medicaid program.
    Keast SL; Thompson D; Farmer K; Smith M; Nesser N; Harrison D
    J Manag Care Spec Pharm; 2014 Jun; 20(6):612-21. PubMed ID: 24856599
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Montelukast and Neuropsychiatric Events in Children with Asthma: A Nested Case-Control Study.
    Glockler-Lauf SD; Finkelstein Y; Zhu J; Feldman LY; To T
    J Pediatr; 2019 Jun; 209():176-182.e4. PubMed ID: 30905424
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk of neuropsychiatric adverse events associated with the use of oseltamivir: a nationwide population-based case-crossover study.
    Kang HR; Lee EK; Kim WJ; Shin JY
    J Antimicrob Chemother; 2019 Feb; 74(2):453-461. PubMed ID: 30418537
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Patient characteristics and prescription fill patterns for allergic rhinitis medications, with a focus on montelukast, in a commercially insured population.
    Bollinger ME; Diette GB; Chang CL; Stephenson JJ; Sajjan SG; Fan T; Allen-Ramey FC
    Clin Ther; 2010 Jun; 32(6):1093-102. PubMed ID: 20637964
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Exploring the possible association between montelukast and neuropsychiatric events among children with asthma: a matched nested case-control study.
    Ali MM; O'Brien CE; Cleves MA; Martin BC
    Pharmacoepidemiol Drug Saf; 2015 Apr; 24(4):435-45. PubMed ID: 25683909
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Montelukast, a leukotriene receptor antagonist, for the treatment of persistent asthma in children aged 2 to 5 years.
    Knorr B; Franchi LM; Bisgaard H; Vermeulen JH; LeSouef P; Santanello N; Michele TM; Reiss TF; Nguyen HH; Bratton DL
    Pediatrics; 2001 Sep; 108(3):E48. PubMed ID: 11533366
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessing the risk of intentional self-harm in montelukast users: an updated Sentinel System analysis using ICD-10 coding.
    Apata J; Lyons JG; Bradley MC; Ma Y; Kempner ME; Kim I; Eworuke E; Pennap D; Mosholder A
    J Asthma; 2024 Jul; 61(7):653-662. PubMed ID: 38064517
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of montelukast on rhinitis symptoms in patients with asthma and seasonal allergic rhinitis.
    Philip G; Nayak AS; Berger WE; Leynadier F; Vrijens F; Dass SB; Reiss TF
    Curr Med Res Opin; 2004 Oct; 20(10):1549-58. PubMed ID: 15462688
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Should we use montelukast in wheezy children?
    Haq I; Harris C; Taylor J; McKean MC; Brodlie M
    Arch Dis Child; 2017 Nov; 102(11):997-998. PubMed ID: 28780506
    [No Abstract]   [Full Text] [Related]  

  • 12. Management of Asthma in School age Children On Therapy (MASCOT): a randomised, double-blind, placebo-controlled, parallel study of efficacy and safety.
    Lenney W; McKay AJ; Tudur Smith C; Williamson PR; James M; Price D;
    Health Technol Assess; 2013 Feb; 17(4):1-218. PubMed ID: 23380178
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy and safety of montelukast in adults with asthma and allergic rhinitis.
    Virchow JC; Bachert C
    Respir Med; 2006 Nov; 100(11):1952-9. PubMed ID: 16626955
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Review of recent results of montelukast use as a monotherapy in children with mild asthma.
    Wahn U; Dass SB
    Clin Ther; 2008; 30 Spec No():1026-35. PubMed ID: 18640477
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The leukotriene receptor antagonist Montelukast can induce adverse skin reactions in asthmatic patients.
    Di Salvo E; Patella V; Casciaro M; Gangemi S
    Pulm Pharmacol Ther; 2020 Feb; 60():101875. PubMed ID: 31837440
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Healthcare utilisation and costs associated with adding montelukast to current therapy in patients with mild to moderate asthma and co-morbid allergic rhinitis: PRAACTICAL study.
    Dal Negro R; Piskorz P; Vives R; Guilera M; Sazonov Kocevar V; Badia X
    Pharmacoeconomics; 2007; 25(8):665-76. PubMed ID: 17640108
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [What is the role of montelukast in asthma treatment?].
    Aksu K; Aksu F
    Tuberk Toraks; 2020 Sep; 68(3):328-330. PubMed ID: 33295731
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Randomized, Multicenter, Double-blind, Phase III Study to Evaluate the Efficacy on Allergic Rhinitis and Safety of a Combination Therapy of Montelukast and Levocetirizine in Patients With Asthma and Allergic Rhinitis.
    Kim MK; Lee SY; Park HS; Yoon HJ; Kim SH; Cho YJ; Yoo KH; Lee SK; Kim HK; Park JW; Park HW; Chung JH; Choi BW; Lee BJ; Chang YS; Jo EJ; Lee SY; Cho YS; Jee YK; Lee JM; Jung J; Park CS
    Clin Ther; 2018 Jul; 40(7):1096-1107.e1. PubMed ID: 29945738
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative study of budesonide inhalation suspension and montelukast in young children with mild persistent asthma.
    Szefler SJ; Baker JW; Uryniak T; Goldman M; Silkoff PE
    J Allergy Clin Immunol; 2007 Nov; 120(5):1043-50. PubMed ID: 17983871
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oral montelukast versus inhaled beclomethasone in 6- to 11-year-old children with asthma: results of an open-label extension study evaluating long-term safety, satisfaction, and adherence with therapy.
    Maspero JF; Dueñas-Meza E; Volovitz B; Pinacho Daza C; Kosa L; Vrijens F; Leff JA
    Curr Med Res Opin; 2001; 17(2):96-104. PubMed ID: 11759189
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.